Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,108.40
(
-0.41%
)
US TECH 100
26,409.60
(
1.35%
)
Dow Jones
49,310.32
(
0.00%
)
Brent Oil
99.39
(
-1.79%
)
Bitcoin
78,292.01
(
0.02%
)
News Focus
News Focus
Post# of 447455
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

JRoon71

Send PM Follow Ignore
Followers 22
Posts 4660
Boards Moderated 0
Alias Born 01/27/2022

JRoon71

Re: Number sleven post# 438332

Wednesday, 08/27/2025 1:07:19 PM

Wednesday, August 27, 2025 1:07:19 PM

Post# of 447455
But doesn't that support my point? This was a Japanese study on Mochida's MND-2119 (essentially the same drug as Lr-EtEPA). It was designed to achieve safety and efficacy data.

Would the FDA accept this trial data?

Maybe I'm missing your point.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AMRN News
More AMRN News